Objectives: How to adapt your neuromodulator treatments to different patients to achieve optimal results.

Introduction: The use of neuromodulator in upper third of the face is the most common aesthetic treatment worldwide. Achieving good cosmetic results demands understanding of the anatomy. We know there is a individual difference in anatomy and different patients have different patterns in their muscle activity so to achieve the best results the doctor needs to be able to read the dynamics of the muscles and predict the outcome of the treatment.

Materials / method: Treating the upper third of the face without creating brow ptosis or Mefisto effect can be done in all patients. Here different movement patterns and how to evaluate different patients in treating the forehead will be shown.

Results: Using different patterns and doses after reading your patient increases patient satisfaction and reduces the risk of unwanted cosmetic results.

Conclusion: Individualized neuromodulator treatments reduces the risk of brow ptosis or Mefisto and will increase patient satisfaction.

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Objectives: The use of botulinum toxin in the treatment of the forehead has long since become established and has replaced the use of intradermal fillers in wrinkles. However, it happens sometimes that the effect appears short-lived and unsatisfactory for patients and doctors. Often this is related to a thinning of the subcutaneous tissue and a relaxation of the skin resulting in frontal skeletonization and change in the bone morphology of the forehead.

Introduction: The use of botulinum toxin in the treatment of the forehead has long since become established and has replaced the use of intradermal fillers in wrinkles. However, it happens sometimes that the effect appears short-lived and unsatisfactory for patients and doctors. Often this is related to a thinning of the subcutaneous tissue and a relaxation of the skin resulting in frontal skeletonization and change in the bone morphology of the forehead.

Materials / method: The combined treatment of toxin and hyaluronic acid is possible in the same session because it is performed on different levels. The HA and toxin is placed deep under the frontal muscle in a plane above the muscle. The injections are performed in a chequered pattern, alternating the injection points of hyaluronic acid and botulinum toxin.

Results: 20 patients have been treated with this "Chessboard technique". There were no major complications. The results were long-lasting and very satisfactory even for the patients.

Conclusion: We bring the results of both feasibility and safety of this method.

Disclosures

Did you receive any funding to support your research for this TOPIC?
Yes
Please specify entities (individual, company, society): Merz

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
Yes
Please specify entities (individual, company, society): Merz

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Objectives: The lecture will briefly describe masseter hypertrophy and its differential diagnosis, the differences in treating it with botulinum toxin compared to conventional tecnihques for mimic muscles, proper patient selection and injection techniques to achieve optimal results in lower facial contouring

Introduction: The main function of masseter muscle is to elevate of the mandible, but it plays an important morphological role in delineating the lower facial contour as well.
Potential causes of masseter hypertrophy include work (functional) hypertrophy from chewing, mental stress and bruxism or benign hypertrophy, secondary to an increased number of muscle fibers.

Materials / method: A series of treated patient is presented along with a instrumental evaluation of success rate: all of them have been treated my mean a standard injection technique

Results: The results are showed by patient pics and a quantitative evaluation is presented in order to further standardize the result

Conclusion: Injection of Botulinum toxin type A into masseter muscle is generally considered a less invasive modality compared to surgical alternatives, and has been advocated for cosmetic sculpting of the lower face, as presented.

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
Yes
Please specify entities (individual, company, society): medical adviser

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability